Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters and the author.
The Department of Government Efficiency (DOGE) this week claimed it had canceled 30 leases for US Food and Drug Administration (FDA) facilities nationwide, including a facility in St. Louis, MO, which is crucial to the agency’s drug testing operations. The department claims the cancellations will save almost $9M over the next year and at least $29.6 million in total. Read Full Article
FDA Matters provides short-form analysis of FDA policy and regulatory issues. We know you are busy, so we publish 1 to 2 columns per week, each a 3-5 minute read.
FDA Matters does not report the news….we provide analysis of what’s behind the news.
FDA Matters advocates for a more effective, efficient, and fair FDA.
Steven A. Grossman, JD, is the founder and author of FDA Matters. Read more about Steven here.